Combo – Pharmaceutical and Medical Device Subjects Insider Intelligence
Ensuring Pharmaceutical and Medical Device products adhere to the highest standards is a testament to the value organizations place on patient safety and efficacy. Maintaining robust quality standards has never been more critical.
When it comes to manufacturing Pharmaceutical and Medical Devices, now more than ever it pays to be informed on what is expected by the consumer, the industry and the governing entities in order to mitigate risk. The question is how do you keep all that information straight? Being well-informed will give you an edge over your competition. At ComplyFDA, Inc., we offer solutions that will help you decipher what’s expected, overcome challenges, mitigate risk and limit liability.
Risk management in pharmaceutical development and distribution is a critical success factor to ensure quality products to patients. Organizations in this regulated industry successfully balance compliance requirements with business processes supporting the development, manufacture and distribution of pharmaceuticals. We offer tools for effectively balancing the compliance requirements with the supporting business process excellence.
Combination Product Insider Intelligence Quarterly
$74.99
Description
This quarterly newsletter provides over 15 charts and graphs providing clear graphical data highlighting current regulatory trends for pharmaceuticals and medical devices. An executive summary provides a synopsis of all data presented in the newsletter and significant points of interest highlighting changes in regulatory trends. Current Good Manufacturing Practices, Packaging and Clinical categories are reported followed by identification of the top 8 citations each for pharmaceuticals and medical devices. Active links to all Warning Letters for the 2 yr time period reported are provided as well as links to FDA regulations for easy reference eliminating FDA website navigation. Among the many uses, newsletters are used to objectively evaluate risk, prioritize audit observations and corrective actions, prepare for internal audits and as training tools in addition to defining regulatory.



